Synairgen
Synairgen is a respiratory biotech company focused on developing inhaled interferon beta (IFN-?) for the treatment of severe viral lung infections. They are working on a host-directed, broad-spectrum antiviral treatment delivered directly into the lungs.
- Inhaled interferon beta (IFN-β)
- Broad-spectrum antiviral treatments
- Clinical trials for respiratory infections
Locations
Company Details
Synairgen is operated by Synairgen Limited and is a Active company incorporated on 16 September 2004 with the registered office located in Southampton, Hampshire. Synairgen Limited was registered 21 years ago.
Status
Active
Size
Small
Directors
5
Age
21 years old
Employees
34
Turnover
Unreported
Total Assets
£7.82M
Cash in Bank
£4.55M
Total Liabilities
-£1.54M